Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in September:

• The Janney Healthcare Conference 2019 on Monday, September 9^th in New York City. Management will present at 8:15 a.m. ET and will also participate in investor meetings.
   
• The H.C. Wainwright 21^st Annual Global Investment Conference on Tuesday, September 10^th in New York City. Management will present at 11:15 a.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
[email protected]

You May Also Be Interested In

• Crypto News Today: AlphaPepe Presale Nears $2.3M Raised as Bitcoin Price Prediction Eyes $250,000
• Stonegate Firm Ranks No. 18 on the 2026 Inc. 5000, Now the Largest Timeshare Exit Company
• Computer Modelling Group Announces First Quarter Results and Quarterly Dividend